Risk Factors for Viral Infection after Liver Transplantation: A Retrospective Study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00010672

Enrollment

530

Registered

2016-07-11

Start date

2013-01-01

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Viral infection

Interventions

Group 1: We investigate all patients at the surgical University Hospital Heidelberg who received a liver transplantation during the study period. Blood samples were taken within the first three month

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Liver transplantation at the university hospitral Heidelberg

Exclusion criteria

Exclusion criteria: incomplete data sets

Design outcomes

Primary

Measure	Time frame
Detection of viral infection after Livertransplantation. Postoperative viral infections were diagnosed by detection of specific IgM antibodies and clinical symptoms such as fever, thrombocytopenia, vesicular/ulcerated lesions (HSV), Ground-glass opacification of the lung (CMV), or hepatic dysfunction. An active CMV infection was defined as at least one pp65-positive cell per 2×10high5 circulating polymorphonuclear neutrophils.	—

Measure

Time frame

Detection of viral infection after Livertransplantation. Postoperative viral infections were diagnosed by detection of specific IgM antibodies and clinical symptoms such as fever, thrombocytopenia, vesicular/ulcerated lesions (HSV), Ground-glass opacification of the lung (CMV), or hepatic dysfunction. An active CMV infection was defined as at least one pp65-positive cell per 2×10high5 circulating polymorphonuclear neutrophils.

—

Secondary

Measure	Time frame
Detection of risk factors for viral infection. A binary multivariate logistic regression model was calculated to identify possible risk factors for the event “viral infection”.	—

Countries

Germany

Contacts

Public ContactMarcel Hochreiter

Klinik für AnästhesiologieUniversität Heidelberg

marcel.hochreiter@med.uni-heidelberg.de062215639445

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Mar 6, 2026